Highlights and Quick Summary
- Annual ROE for 2022 was -85.38% (a 15.24% increase from previous year)
- Annual ROE for 2021 was -74.09% (a 3904.86% increase from previous year)
- Annual ROE for 2020 was -1.85% (a -98.07% decrease from previous year)
- Twelve month ROE ending June 30, 2023 was -171.11% (a 47.64% increase compared to previous quarter)
- Twelve month trailing ROE increased by 165.41% year-over-year
Trailing ROE for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -171.11% | -115.9% | -85.38% | -64.47% |
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROE of DURECT Corporation
Most recent ROEof DRRX including historical data for past 10 years.Interactive Chart of ROE of DURECT Corporation
DURECT Corporation ROE for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -85.38% |
| 2021 | – | – | – | – | -74.09% |
| 2020 | – | – | – | – | -1.85% |
| 2019 | – | – | – | – | -96.02% |
| 2018 | – | – | – | – | -122.07% |
| 2017 | – | – | – | – | -24.78% |
| 2016 | – | – | – | – | -297.22% |
| 2015 | – | – | – | – | -135.71% |
| 2014 | – | – | – | – | -89.81% |
| 2013 | – | – | – | – | -63.99% |
| 2012 | – | – | – | – | 81.39% |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic